• Català
  • Castellano
  • English
  • Cancer Prevention and Control Program
    • Biomarkers
      • Group
      • Research
      • Projects
      • Publications
      • Applications
      • Contact
    • Tobacco
      • Group
      • Research
      • Projects
      • Publications
      • Applications
      • Contact
    • Screening
      • Group
      • Research
      • Projects
      • Publications
      • Contact
  • Education & Teaching
  • Work with us
  • How to arrive

            hubc.png

Home ›

Publications

  • List
  • Filter
  • Author  (Asc)
  • Keyword
  • Title
  • Type
  • Year
Filters: Author is Paez, D  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
Paez D, Paré L, Espinosa I, Salazar J, del Rio E, Barnadas A, et al. Immunoglobulin G fragment C receptor polymorphisms and KRAS mutations: are they useful biomarkers of clinical outcome in advanced colorectal cancer treated with anti-EGFR-based therapy? Cancer science. 2010;101(9):2048-53. Abstract
Paré L, Paez D, Salazar J, del Rio E, Tizzano E, Marcuello E, et al. Absence of large intragenic rearrangements in the DPYD gene in a large cohort of colorectal cancer patients treated with 5-FU-based chemotherapy. British journal of clinical pharmacology. 2010;70(2):268-72. Abstract
Paré L, Salazar J, del Rio E, Baiget M, Altés A, Marcuello E, et al. Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy in females. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008;26(20):3468; author reply 3468-9.

© Catalan Institute of Oncology

Syndicate content